Global Alzheimer's Disease Epidemiology, Patient Flow, Prevalence and Diagnosed & Treated Patients Analysis - 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Global Alzheimer's Disease Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

This research provides insights into Alzheimer's Disease epidemiology, Alzheimer's Disease diagnosed patients, and Alzheimer's Disease treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Alzheimer's Disease derived from epidemiological analysis, patients diagnosed with Alzheimer's Disease, and patients treated with a drug therapy.

The research study helps executives estimate Alzheimer's Disease market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Alzheimer's Disease prevalence, Alzheimer's Disease diagnosis rate, and Alzheimer's Disease treatment rate for the period 2017-2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features

  • Alzheimer's Disease Patient Flow
  • Alzheimer's Disease Prevalence
  • Alzheimer's Disease Diagnosed Patients
  • Alzheimer's Disease Treated Patients

Key Topics Covered

1. Alzheimer's Disease: Disease Definition

2. Global Alzheimer's Disease Patient Flow

2A. Global Alzheimer's Disease Prevalence

2B. Global Alzheimer's Disease Diagnosed Patients

2C. Global Alzheimer's Disease Treated Patients

3. Alzheimer's Disease Patient Flow in the US

3A. Alzheimer's Disease Prevalence in the US

3B. Alzheimer's Disease Diagnosed Patients in the US

3C. Alzheimer's Disease Treated Patients in the US

4. Alzheimer's Disease Patient Flow in Europe

4A. Alzheimer's Disease Prevalence in Europe

4B. Alzheimer's Disease Diagnosed Patients in Europe

4C. Alzheimer's Disease Treated Patients in Europe

5. Alzheimer's Disease Patient Flow in Germany

5A. Alzheimer's Disease Prevalence in Germany

5B. Alzheimer's Disease Diagnosed Patients in Germany

5C. Alzheimer's Disease Treated Patients in Germany

6. Alzheimer's Disease Patient Flow in France

6A. Alzheimer's Disease Prevalence in France

6B. Alzheimer's Disease Diagnosed Patients in France

6C. Alzheimer's Disease Treated Patients in France

7. Alzheimer's Disease Patient Flow in Spain

7A. Alzheimer's Disease Prevalence in Spain

7B. Alzheimer's Disease Diagnosed Patients in Spain

7C. Alzheimer's Disease Treated Patients in Spain

8. Alzheimer's Disease Patient Flow in Italy

8A. Alzheimer's Disease Prevalence in Italy

8B. Alzheimer's Disease Diagnosed Patients in Italy

8C. Alzheimer's Disease Treated Patients in Italy

9. Alzheimer's Disease Patient Flow in UK

9A. Alzheimer's Disease Prevalence in UK

9B. Alzheimer's Disease Diagnosed Patients in UK

9C. Alzheimer's Disease Treated Patients in UK

10. Alzheimer's Disease Patient Flow in Japan

10A. Alzheimer's Disease Prevalence in Japan

10B. Alzheimer's Disease Diagnosed Patients in Japan

10C. Alzheimer's Disease Treated Patients in Japan

11. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/nqnf4d/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Alzheimer's Disease Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Alzheimer's Disease Drugs